Review




Structured Review

Promega chicken polyclonal anti-bdnf
KEY RESOURCE TABLE
Chicken Polyclonal Anti Bdnf, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chicken+polyclonal+anti-bdnf/chicken+anti+bdnf/pmc07725275-15-0-4
Average 90 stars, based on 1 article reviews
chicken polyclonal anti-bdnf - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss"

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss

Journal: Cell reports

doi: 10.1016/j.celrep.2018.09.077

KEY RESOURCE TABLE
Figure Legend Snippet: KEY RESOURCE TABLE

Techniques Used: Virus, Recombinant, Transfection, Western Blot, Sequencing, Plasmid Preparation, Expressing, Software

Related Articles

Virus:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Recombinant:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Transfection:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Western Blot:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Sequencing:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Plasmid Preparation:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Expressing:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Software:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Immunostaining:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Avidin-Biotin Assay:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Incubation:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Immunodetection:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Fluorsave:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Double Immunostaining:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Marker:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).

Labeling:

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Article Title: UPREGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN NODOSE GANGLIA AND THE LOWER BRAINSTEM OF HYPERTENSIVE RATS
Article Snippet: Every other section (i.e. one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.
Article Snippet: Every other section (i.e., one series) was processed for BDNF immunostaining with chicken polyclonal anti-BDNF (1:50; Promega), followed by goat anti-chicken biotinylated IgG (1:200; Vector Laboratories, Burlingame, CA) secondary antibody, avidin-biotin reagent (ABC), and diaminobenzidine.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Immunostaining of sections Sections were (1) incubated for 1 h in a 10% solution of goat serum in dilution buffer (DB; 0.02 M phosphate buffer, 0.5 M NaCl, 0.3% Triton X-100), (2) incubated for 2 h in chicken polyclonal anti-BDNF [1:50 (NGs) or 1:25 (brainstems); Promega, Madison, WI] in DB, applied alone, or in combination with either rabbit polyclonal anti-HCN1 (1:100; Alomone Labs, Jerusalem, Israel) or rabbit polyclonal anti-VR1 (TRPV1), N-terminus (1:500; Neuromics, Edina, MN), (3) washed three times in DB, (4) incubated in secondary antibody diluted in DB with 10% goat serum as specified for the following types of immunostaining: (i) NG, immunodetection of BDNF only, 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories, Burlingame, CA), (ii) brainstem, immunodetection of BDNF only, 2 h in donkey anti-chicken IgG-Cy2 (1:200, Jackson Immunoresearch; West Grove, PA), (iii) NG, double immunodetection of either BDNF/HCN1 or BDNF/VR1 (TRPV1), 1 h in goat anti-chicken IgG-Alexa 488 (1:1000, Invitrogen, Carlsbad, CA) and goat anti-rabbit IgG-Alexa 647 (1:1000, Invitrogen, Carlsbad, CA), (5) washed three times in PBS, (6) incubated for 30 min in avidin-biotin reagent (ABC) in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories;), (7) washed for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in diaminobenzidine (DAB) solution (in PBS: 0.3 mg/ml DAB, 0.032% NiCl 2 , 0.0075% H 2 O 2 ), (10) washed three times in PBS, and (11) mounted with Gel Mount (Sigma) or FluorSave (Calbiochem, San Diego, CA).

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: HRP was activated with chemiluminescent reagents (Western Lightning, Perkin-Elmer, Waltham, MA) for 90 sec, and blue X-ray film (Phenix Research, Candler, NC) was exposed for 2 min. Preabsorption with BDNF protein Chicken polyclonal anti-BDNF (Promega, Madison, WI) was preabsorbed by incubation with BDNF-coated beads.

Article Title: Brain-Derived Neurotrophic Factor in Arterial Baroreceptor Pathways: Implications for Activity-Dependent Plasticity at Baroafferent Synapses
Article Snippet: Double-immunostaining of cultures for BDNF and Neurofilament, a pan-neuronal marker Cultures were (1) incubated for 1 h in 1:1 solution of goat serum and PBS-0.1% Triton X-100, (2) incubated for 2 h in chicken polyclonal anti-BDNF (1:100; Promega) alone or combined with mouse monoclonal anti-neurofilament 68 and 160 (1:100; Sigma, St. Louis, MO), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (3) washed one time in PBS followed by two washes in PBS containing 5% goat serum, (4) incubated for 1 h in goat anti-chicken biotinylated IgG (1:200, Vector Laboratories) alone or combined with goat anti-mouse IgG-Cy3 (1:200, Jackson Immunoresearch), diluted in PBS-0.1% Triton X-100 with 10% goat serum, (5) washed in PBS, (6) incubated for 30 min in avidin-biotin reagent in PBS-0.5M NaCl (1:100, Vectastain Elite , Vector Laboratories), (7) incubated for 10 min in PBS-0.5M PBS, (8) washed two times in PBS, (9) incubated for 3–5 min in DAB solution, (10) washed once in PBS, and (11) mounted with ProLong ® Gold (Invitrogen) or Gel Mount (Sigma).

Article Title: TOOTH PULP INFLAMMATION INCREASES BDNF EXPRESSION IN RODENT TRIGEMINAL GANGLION NEURONS
Article Snippet: Double-immunohistochemistry was performed as previously described ( Buldyrev et al., 2006 ; Martin et al., 2009 ) with chicken polyclonal anti-BDNF (1:50; Promega), and either rabbit polyclonal anti-CGRP (1:2000; Calbiochem) or rabbit polyclonal anti-TRPV1 (1:500; Neuromics, Edina, MN).



Similar Products

90
Promega chicken polyclonal anti-bdnf
KEY RESOURCE TABLE
Chicken Polyclonal Anti Bdnf, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chicken+polyclonal+anti-bdnf/chicken+anti+bdnf/pmc07725275-15-0-4
Average 90 stars, based on 1 article reviews
chicken polyclonal anti-bdnf - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Promega polyclonal chicken anti-human bdnf
Plasma <t>BDNF</t> levels according to sex and diagnostic group. BDNF levels in plasma (50 ul) were determined by ELISA. (A) BDNF levels did not differ by sex among subjects included in our study as per Student’s t test, unpaired; two-tailed. (B) No significant differences were detected according to diagnostic group between premanifest (PM), manifest HD (HD), and normal controls (NC) as per One-way ANOVA. Data is shown as individual BDNF levels ± SD.
Polyclonal Chicken Anti Human Bdnf, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chicken+polyclonal+anti-bdnf/recombinant+human+bdnf/pmc06989488-130-2-10
Average 90 stars, based on 1 article reviews
polyclonal chicken anti-human bdnf - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Promega chicken polyclonal anti-bdnf antibody
NGF binds to cell surface MOG on myelin and MOG-expressing CHO cells. Purified oligodendrocyte-DRG co-cultures were established using cells from MOG +/+ and MOG −/− mice to examine binding of NGF to oligodendrocyte myelin internodes, and requirement of MOG for NGF binding to myelin. Internodes were stained for MBP, MOG, and NGF binding. (A) Binding of NGF to MOG +/+ myelin internodes. (B). Absence of NGF-binding to MOG −/− myelin internodes. Magnified images of internodes from the corresponding merged image are shown on the right. Neurotrophin binding to MOG-expressing CHO cells was also examined. CHO or MOG-CHO cells were incubated with increasing concentrations (1–100 ng/ml) of neurotrophins (NGF, NT-3, and <t>BDNF)</t> and analyzed for binding by immunostaining for the respective neurotrophins. (C) Strong of NGF to MOG-CHO cells at 10 ng/ml NGF. (D) Absence of NGF binding to untransfected CHO cells. (E) Intense binding of NGF at 100 ng/ml can be observed against MOG-CHO cells. (F and G) Absent or only weak binding of BDNF or NT-3 to MOG-CHO cells at 100 ng/ml. Bars, 50 µm.
Chicken Polyclonal Anti Bdnf Antibody, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chicken+polyclonal+anti-bdnf/chicken+anti+bdnf/pmc04576870-103-16-20
Average 90 stars, based on 1 article reviews
chicken polyclonal anti-bdnf antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Promega chicken anti-human bdnf polyclonal antibody g1641
Primer sequences used for real-time RT-PCR .
Chicken Anti Human Bdnf Polyclonal Antibody G1641, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chicken+polyclonal+anti-bdnf/chicken+anti+bdnf/pmc03788348-88-1-8
Average 90 stars, based on 1 article reviews
chicken anti-human bdnf polyclonal antibody g1641 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


KEY RESOURCE TABLE

Journal: Cell reports

Article Title: RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss

doi: 10.1016/j.celrep.2018.09.077

Figure Lengend Snippet: KEY RESOURCE TABLE

Article Snippet: Chicken polyclonal anti-BDNF , Promega , Cat#G1641; RRID:AB_430850.

Techniques: Virus, Recombinant, Transfection, Western Blot, Sequencing, Plasmid Preparation, Expressing, Software

Plasma BDNF levels according to sex and diagnostic group. BDNF levels in plasma (50 ul) were determined by ELISA. (A) BDNF levels did not differ by sex among subjects included in our study as per Student’s t test, unpaired; two-tailed. (B) No significant differences were detected according to diagnostic group between premanifest (PM), manifest HD (HD), and normal controls (NC) as per One-way ANOVA. Data is shown as individual BDNF levels ± SD.

Journal: Frontiers in Molecular Neuroscience

Article Title: Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

doi: 10.3389/fnmol.2019.00335

Figure Lengend Snippet: Plasma BDNF levels according to sex and diagnostic group. BDNF levels in plasma (50 ul) were determined by ELISA. (A) BDNF levels did not differ by sex among subjects included in our study as per Student’s t test, unpaired; two-tailed. (B) No significant differences were detected according to diagnostic group between premanifest (PM), manifest HD (HD), and normal controls (NC) as per One-way ANOVA. Data is shown as individual BDNF levels ± SD.

Article Snippet: Subsequently, a polyclonal chicken anti-human BDNF (100 ul; 2.5 μg/ml; Promega) was added to the plate and incubated for 2.5 h. The plate was washed five times with PBST, then anti-chicken IgY-HRP (1 μg/ml; Promega) was added to each well for a 1-h incubation at RT.

Techniques: Clinical Proteomics, Diagnostic Assay, Enzyme-linked Immunosorbent Assay, Two Tailed Test

Correlations between plasma  BDNF  levels and clinical data in HD patients and control subjects.

Journal: Frontiers in Molecular Neuroscience

Article Title: Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

doi: 10.3389/fnmol.2019.00335

Figure Lengend Snippet: Correlations between plasma BDNF levels and clinical data in HD patients and control subjects.

Article Snippet: Subsequently, a polyclonal chicken anti-human BDNF (100 ul; 2.5 μg/ml; Promega) was added to the plate and incubated for 2.5 h. The plate was washed five times with PBST, then anti-chicken IgY-HRP (1 μg/ml; Promega) was added to each well for a 1-h incubation at RT.

Techniques: Clinical Proteomics, Control

Salivary BDNF levels according to sex and diagnostic group. BDNF levels in saliva (50 ul) were determined by ELISA. (A) No significant differences in BDNF were observed by sex (Student’s t test, unpaired; two-tailed). (B) BDNF levels are lower in premanifest (PM) and manifest HD (HD) cases when compared to normal controls (NC). ∗ p < 0.05; ∗∗ p < 0.01 in comparison to NC group as per One-way ANOVA. (C) BDNF levels are significantly lower in subjects who are >10 years from their predicted age of onset compared to those who are <10 years from predicted onset. ∗ p = 0.05. Predicted age to onset was calculated using the Langbehn formula . Data is shown as individual BDNF levels ± SD.

Journal: Frontiers in Molecular Neuroscience

Article Title: Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

doi: 10.3389/fnmol.2019.00335

Figure Lengend Snippet: Salivary BDNF levels according to sex and diagnostic group. BDNF levels in saliva (50 ul) were determined by ELISA. (A) No significant differences in BDNF were observed by sex (Student’s t test, unpaired; two-tailed). (B) BDNF levels are lower in premanifest (PM) and manifest HD (HD) cases when compared to normal controls (NC). ∗ p < 0.05; ∗∗ p < 0.01 in comparison to NC group as per One-way ANOVA. (C) BDNF levels are significantly lower in subjects who are >10 years from their predicted age of onset compared to those who are <10 years from predicted onset. ∗ p = 0.05. Predicted age to onset was calculated using the Langbehn formula . Data is shown as individual BDNF levels ± SD.

Article Snippet: Subsequently, a polyclonal chicken anti-human BDNF (100 ul; 2.5 μg/ml; Promega) was added to the plate and incubated for 2.5 h. The plate was washed five times with PBST, then anti-chicken IgY-HRP (1 μg/ml; Promega) was added to each well for a 1-h incubation at RT.

Techniques: Diagnostic Assay, Enzyme-linked Immunosorbent Assay, Two Tailed Test, Comparison

Correlations between salivary  BDNF  levels and clinical data.

Journal: Frontiers in Molecular Neuroscience

Article Title: Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

doi: 10.3389/fnmol.2019.00335

Figure Lengend Snippet: Correlations between salivary BDNF levels and clinical data.

Article Snippet: Subsequently, a polyclonal chicken anti-human BDNF (100 ul; 2.5 μg/ml; Promega) was added to the plate and incubated for 2.5 h. The plate was washed five times with PBST, then anti-chicken IgY-HRP (1 μg/ml; Promega) was added to each well for a 1-h incubation at RT.

Techniques:

Methylation sites in the BDNF promoter IV region. (A) Schematic representation of human BDNF gene indicating alternative promoters. CpG sites analyzed are detailed in enlarged box. Position is in relation to transcription start site. (B) Detailed sequence of BDNF promoter IV. Underlined text in yellow boxes indicate regions analyzed with each probe by pyrosequencing. Genomic position is based on chromone build GRCh37.p13 primary assembly.

Journal: Frontiers in Molecular Neuroscience

Article Title: Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

doi: 10.3389/fnmol.2019.00335

Figure Lengend Snippet: Methylation sites in the BDNF promoter IV region. (A) Schematic representation of human BDNF gene indicating alternative promoters. CpG sites analyzed are detailed in enlarged box. Position is in relation to transcription start site. (B) Detailed sequence of BDNF promoter IV. Underlined text in yellow boxes indicate regions analyzed with each probe by pyrosequencing. Genomic position is based on chromone build GRCh37.p13 primary assembly.

Article Snippet: Subsequently, a polyclonal chicken anti-human BDNF (100 ul; 2.5 μg/ml; Promega) was added to the plate and incubated for 2.5 h. The plate was washed five times with PBST, then anti-chicken IgY-HRP (1 μg/ml; Promega) was added to each well for a 1-h incubation at RT.

Techniques: Methylation, Sequencing

DNA methylation status at selected CpG sites from  BDNF  promoter IV.

Journal: Frontiers in Molecular Neuroscience

Article Title: Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

doi: 10.3389/fnmol.2019.00335

Figure Lengend Snippet: DNA methylation status at selected CpG sites from BDNF promoter IV.

Article Snippet: Subsequently, a polyclonal chicken anti-human BDNF (100 ul; 2.5 μg/ml; Promega) was added to the plate and incubated for 2.5 h. The plate was washed five times with PBST, then anti-chicken IgY-HRP (1 μg/ml; Promega) was added to each well for a 1-h incubation at RT.

Techniques: DNA Methylation Assay

DNA methylation levels of BDNF promoter IV in blood. Methylation was quantified by pyrosequencing and expressed as mean percent methylation representing the averaged value of cases (HD Gene+) or control subjects (NC) for each of individual CpG. Data represents mean value ± SEM. ∗ p < 0.05 as per two-tailed Student’s t -test.

Journal: Frontiers in Molecular Neuroscience

Article Title: Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

doi: 10.3389/fnmol.2019.00335

Figure Lengend Snippet: DNA methylation levels of BDNF promoter IV in blood. Methylation was quantified by pyrosequencing and expressed as mean percent methylation representing the averaged value of cases (HD Gene+) or control subjects (NC) for each of individual CpG. Data represents mean value ± SEM. ∗ p < 0.05 as per two-tailed Student’s t -test.

Article Snippet: Subsequently, a polyclonal chicken anti-human BDNF (100 ul; 2.5 μg/ml; Promega) was added to the plate and incubated for 2.5 h. The plate was washed five times with PBST, then anti-chicken IgY-HRP (1 μg/ml; Promega) was added to each well for a 1-h incubation at RT.

Techniques: DNA Methylation Assay, Methylation, Control, Two Tailed Test

Correlations between  BDNF  promoter IV methylation and clinical measures in HD patients.

Journal: Frontiers in Molecular Neuroscience

Article Title: Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

doi: 10.3389/fnmol.2019.00335

Figure Lengend Snippet: Correlations between BDNF promoter IV methylation and clinical measures in HD patients.

Article Snippet: Subsequently, a polyclonal chicken anti-human BDNF (100 ul; 2.5 μg/ml; Promega) was added to the plate and incubated for 2.5 h. The plate was washed five times with PBST, then anti-chicken IgY-HRP (1 μg/ml; Promega) was added to each well for a 1-h incubation at RT.

Techniques: Methylation

NGF binds to cell surface MOG on myelin and MOG-expressing CHO cells. Purified oligodendrocyte-DRG co-cultures were established using cells from MOG +/+ and MOG −/− mice to examine binding of NGF to oligodendrocyte myelin internodes, and requirement of MOG for NGF binding to myelin. Internodes were stained for MBP, MOG, and NGF binding. (A) Binding of NGF to MOG +/+ myelin internodes. (B). Absence of NGF-binding to MOG −/− myelin internodes. Magnified images of internodes from the corresponding merged image are shown on the right. Neurotrophin binding to MOG-expressing CHO cells was also examined. CHO or MOG-CHO cells were incubated with increasing concentrations (1–100 ng/ml) of neurotrophins (NGF, NT-3, and BDNF) and analyzed for binding by immunostaining for the respective neurotrophins. (C) Strong of NGF to MOG-CHO cells at 10 ng/ml NGF. (D) Absence of NGF binding to untransfected CHO cells. (E) Intense binding of NGF at 100 ng/ml can be observed against MOG-CHO cells. (F and G) Absent or only weak binding of BDNF or NT-3 to MOG-CHO cells at 100 ng/ml. Bars, 50 µm.

Journal: The Journal of Cell Biology

Article Title: The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry

doi: 10.1083/jcb.201504106

Figure Lengend Snippet: NGF binds to cell surface MOG on myelin and MOG-expressing CHO cells. Purified oligodendrocyte-DRG co-cultures were established using cells from MOG +/+ and MOG −/− mice to examine binding of NGF to oligodendrocyte myelin internodes, and requirement of MOG for NGF binding to myelin. Internodes were stained for MBP, MOG, and NGF binding. (A) Binding of NGF to MOG +/+ myelin internodes. (B). Absence of NGF-binding to MOG −/− myelin internodes. Magnified images of internodes from the corresponding merged image are shown on the right. Neurotrophin binding to MOG-expressing CHO cells was also examined. CHO or MOG-CHO cells were incubated with increasing concentrations (1–100 ng/ml) of neurotrophins (NGF, NT-3, and BDNF) and analyzed for binding by immunostaining for the respective neurotrophins. (C) Strong of NGF to MOG-CHO cells at 10 ng/ml NGF. (D) Absence of NGF binding to untransfected CHO cells. (E) Intense binding of NGF at 100 ng/ml can be observed against MOG-CHO cells. (F and G) Absent or only weak binding of BDNF or NT-3 to MOG-CHO cells at 100 ng/ml. Bars, 50 µm.

Article Snippet: NGF was identified by a rabbit polyclonal anti-NGF antibody (Sigma-Aldrich), and BDNF was identified by a chicken polyclonal anti-BDNF antibody (Promega) and a chicken polyclonal anti–NT-3 antibody (Promega).

Techniques: Expressing, Purification, Binding Assay, Staining, Incubation, Immunostaining

Primer sequences used for real-time RT-PCR .

Journal: Frontiers in Synaptic Neuroscience

Article Title: Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

doi: 10.3389/fnsyn.2013.00007

Figure Lengend Snippet: Primer sequences used for real-time RT-PCR .

Article Snippet: A chicken anti-human BDNF polyclonal antibody (1:100, G1641, Promega), a sheep anti-α-MSH antibody (1:30,000, AB5087, Chemicon, Temecula, CA), a biotinylated rabbit anti-chicken IgY (1:300, G2891, Promega), a biotinylated rabbit anti-sheep IgG (1:300, BA-6000, Vector Laboratories, Burlingame, CA) were used.

Techniques: Quantitative RT-PCR, Amplification

Reduction of GLUT2 paralleled with reduction of BDNF expression in GK rats. (A) GLUT4, GLUT8 and gluokinase mRNA expressions in VMH were unchanged in GK rats at 26 weeks. (B) GLUT2 mRNA expression in VMH was significantly reduced in GK rats at 26 weeks, but not at 11 weeks ( * p < 0.05, Student's t -test). (C) Effects of icv 2-DG injection on BDNF mRNA levels in VMH were determined at 2 h after icv injection of 2-DG (5 mg/10 μ l) or saline (Sal). BDNF mRNA expression in VMH and hippocampus (Hp) was significantly reduced by 2-DG ( * p < 0.05, Student's t -test). (D) Treatment with 2-DG for 3 h dose-dependently suppressed BDNF mRNA level in cultured mediobasal hypothalamic cells. The effects of 12 and 16 mM 2-DG were significant ( * p < 0.05, One-Way ANOVA with Holm's post-hoc test).

Journal: Frontiers in Synaptic Neuroscience

Article Title: Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

doi: 10.3389/fnsyn.2013.00007

Figure Lengend Snippet: Reduction of GLUT2 paralleled with reduction of BDNF expression in GK rats. (A) GLUT4, GLUT8 and gluokinase mRNA expressions in VMH were unchanged in GK rats at 26 weeks. (B) GLUT2 mRNA expression in VMH was significantly reduced in GK rats at 26 weeks, but not at 11 weeks ( * p < 0.05, Student's t -test). (C) Effects of icv 2-DG injection on BDNF mRNA levels in VMH were determined at 2 h after icv injection of 2-DG (5 mg/10 μ l) or saline (Sal). BDNF mRNA expression in VMH and hippocampus (Hp) was significantly reduced by 2-DG ( * p < 0.05, Student's t -test). (D) Treatment with 2-DG for 3 h dose-dependently suppressed BDNF mRNA level in cultured mediobasal hypothalamic cells. The effects of 12 and 16 mM 2-DG were significant ( * p < 0.05, One-Way ANOVA with Holm's post-hoc test).

Article Snippet: A chicken anti-human BDNF polyclonal antibody (1:100, G1641, Promega), a sheep anti-α-MSH antibody (1:30,000, AB5087, Chemicon, Temecula, CA), a biotinylated rabbit anti-chicken IgY (1:300, G2891, Promega), a biotinylated rabbit anti-sheep IgG (1:300, BA-6000, Vector Laboratories, Burlingame, CA) were used.

Techniques: Expressing, Injection, Saline, Cell Culture

Effect of icv BDNF treatment daily for 6 days on plasma leptin levels in GK rats. Plasma leptin levels at 0, 6th, 10th, 21st days after beginning of BDNF or vehicle injections. BDNF treatment significantly reduced plasma leptin level in GK rats. * p < 0.05 vs. other groups (One-Way ANOVA with Holm's post-hoc test).

Journal: Frontiers in Synaptic Neuroscience

Article Title: Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

doi: 10.3389/fnsyn.2013.00007

Figure Lengend Snippet: Effect of icv BDNF treatment daily for 6 days on plasma leptin levels in GK rats. Plasma leptin levels at 0, 6th, 10th, 21st days after beginning of BDNF or vehicle injections. BDNF treatment significantly reduced plasma leptin level in GK rats. * p < 0.05 vs. other groups (One-Way ANOVA with Holm's post-hoc test).

Article Snippet: A chicken anti-human BDNF polyclonal antibody (1:100, G1641, Promega), a sheep anti-α-MSH antibody (1:30,000, AB5087, Chemicon, Temecula, CA), a biotinylated rabbit anti-chicken IgY (1:300, G2891, Promega), a biotinylated rabbit anti-sheep IgG (1:300, BA-6000, Vector Laboratories, Burlingame, CA) were used.

Techniques: Clinical Proteomics

Effect of BDNF treatment on food intake and body weight in GK rats. (A) Daily food intake was examined before and after BDNF treatment (15 μ g/5 μ l saline/head) for 6 days. BDNF treatment significantly reduced daily food intake during period of treatment in both GK-BDNF and Wistar-BDNF groups. * p < 0.05 vs. other groups (One-Way ANOVA with Holm's post-hoc test). (B) Body weight was examined before and after treatment of BDNF for 6 days. BDNF treatment significantly reduced body weight in both GK-BDNF and Wistar-BDNF groups. * p < 0.05 vs. other groups (One-Way ANOVA with Holm's post-hoc test).

Journal: Frontiers in Synaptic Neuroscience

Article Title: Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

doi: 10.3389/fnsyn.2013.00007

Figure Lengend Snippet: Effect of BDNF treatment on food intake and body weight in GK rats. (A) Daily food intake was examined before and after BDNF treatment (15 μ g/5 μ l saline/head) for 6 days. BDNF treatment significantly reduced daily food intake during period of treatment in both GK-BDNF and Wistar-BDNF groups. * p < 0.05 vs. other groups (One-Way ANOVA with Holm's post-hoc test). (B) Body weight was examined before and after treatment of BDNF for 6 days. BDNF treatment significantly reduced body weight in both GK-BDNF and Wistar-BDNF groups. * p < 0.05 vs. other groups (One-Way ANOVA with Holm's post-hoc test).

Article Snippet: A chicken anti-human BDNF polyclonal antibody (1:100, G1641, Promega), a sheep anti-α-MSH antibody (1:30,000, AB5087, Chemicon, Temecula, CA), a biotinylated rabbit anti-chicken IgY (1:300, G2891, Promega), a biotinylated rabbit anti-sheep IgG (1:300, BA-6000, Vector Laboratories, Burlingame, CA) were used.

Techniques: Saline

Intraperitoneal glucose tolerance test before and after BDNF treatment in GK rats. BDNF treatment did not attenuate glucose intolerance (A) and impaired insulin release (B) during glucose tolerance test in GK rats throughout experiment. (A) * p < 0.05 vs. GK-Vehicle and GK-BDNF (One-Way ANOVA with Holm's post-hoc test). (B) * p < 0.05 vs. GK-Vehicle in Day 0 (30 min), Day 7 (15 min), * p < 0.05 vs. GK-BDNF in Day 7 (15 min, 30 min) and 11 (15 min), One-Way ANOVA with Holm's post-hoc test.

Journal: Frontiers in Synaptic Neuroscience

Article Title: Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

doi: 10.3389/fnsyn.2013.00007

Figure Lengend Snippet: Intraperitoneal glucose tolerance test before and after BDNF treatment in GK rats. BDNF treatment did not attenuate glucose intolerance (A) and impaired insulin release (B) during glucose tolerance test in GK rats throughout experiment. (A) * p < 0.05 vs. GK-Vehicle and GK-BDNF (One-Way ANOVA with Holm's post-hoc test). (B) * p < 0.05 vs. GK-Vehicle in Day 0 (30 min), Day 7 (15 min), * p < 0.05 vs. GK-BDNF in Day 7 (15 min, 30 min) and 11 (15 min), One-Way ANOVA with Holm's post-hoc test.

Article Snippet: A chicken anti-human BDNF polyclonal antibody (1:100, G1641, Promega), a sheep anti-α-MSH antibody (1:30,000, AB5087, Chemicon, Temecula, CA), a biotinylated rabbit anti-chicken IgY (1:300, G2891, Promega), a biotinylated rabbit anti-sheep IgG (1:300, BA-6000, Vector Laboratories, Burlingame, CA) were used.

Techniques:

Effect of BDNF treatment on casual blood glucose level in GK rats. Although BDNF did not alter blood glucose level during treatment, significant reduction of blood glucose level was observed after termination of BDNF treatment in GK-BDNF group ( * p < 0.05 vs. other groups, One-Way ANOVA with Holm's post-hoc test).

Journal: Frontiers in Synaptic Neuroscience

Article Title: Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

doi: 10.3389/fnsyn.2013.00007

Figure Lengend Snippet: Effect of BDNF treatment on casual blood glucose level in GK rats. Although BDNF did not alter blood glucose level during treatment, significant reduction of blood glucose level was observed after termination of BDNF treatment in GK-BDNF group ( * p < 0.05 vs. other groups, One-Way ANOVA with Holm's post-hoc test).

Article Snippet: A chicken anti-human BDNF polyclonal antibody (1:100, G1641, Promega), a sheep anti-α-MSH antibody (1:30,000, AB5087, Chemicon, Temecula, CA), a biotinylated rabbit anti-chicken IgY (1:300, G2891, Promega), a biotinylated rabbit anti-sheep IgG (1:300, BA-6000, Vector Laboratories, Burlingame, CA) were used.

Techniques:

Effect of  BDNF  on interscapular, epidiymal, mesenteric and perirenal fat weights (% body weight) in GK rats .

Journal: Frontiers in Synaptic Neuroscience

Article Title: Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

doi: 10.3389/fnsyn.2013.00007

Figure Lengend Snippet: Effect of BDNF on interscapular, epidiymal, mesenteric and perirenal fat weights (% body weight) in GK rats .

Article Snippet: A chicken anti-human BDNF polyclonal antibody (1:100, G1641, Promega), a sheep anti-α-MSH antibody (1:30,000, AB5087, Chemicon, Temecula, CA), a biotinylated rabbit anti-chicken IgY (1:300, G2891, Promega), a biotinylated rabbit anti-sheep IgG (1:300, BA-6000, Vector Laboratories, Burlingame, CA) were used.

Techniques:

Expressions of BDNF mRNA and BDNF-immunoreactive cells in Wistar and GK rats at 11 and 26 weeks of age. (A) BDNF mRNA levels in VMH of Wistar and GK rats. Significant reduction of BDNF mRNA level was found in GK rats at 26 weeks of age ( * p < 0.05, Student's t -test). (B) At 26 weeks, significant reduction of the number of BDNF-immunoreactive neurons was found in VMH, but not PVN and NTS, of GK rats ( * p < 0.05, Two-Way ANOVA with Tukey's post-hoc test). This reduction in VMH was not different at 11 weeks. (C–J) Representative images of BDNF-immunoreactive neurons in Wistar rats (C,E,G,I) and GK rats (D,F,H,J) at 26 weeks of age. Broken lines in each image indicate the outline of PVN (C,D) and VMH (E,F) . No apparent difference was found in the PVN (C,D) and NTS (G,H) . By contrast, the number of BDNF-immunoreactive neurons in the VMH of GK rats (F) was fewer than that of Wistar rats (E) . At higher magnification, the difference between Wistar (I) and GK (J) rats was obvious. III; the third ventricle, IV; the fourth ventricle, cc; central canal. Scale bar = 500 μm (C–H) or 100 μm (I and J) .

Journal: Frontiers in Synaptic Neuroscience

Article Title: Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

doi: 10.3389/fnsyn.2013.00007

Figure Lengend Snippet: Expressions of BDNF mRNA and BDNF-immunoreactive cells in Wistar and GK rats at 11 and 26 weeks of age. (A) BDNF mRNA levels in VMH of Wistar and GK rats. Significant reduction of BDNF mRNA level was found in GK rats at 26 weeks of age ( * p < 0.05, Student's t -test). (B) At 26 weeks, significant reduction of the number of BDNF-immunoreactive neurons was found in VMH, but not PVN and NTS, of GK rats ( * p < 0.05, Two-Way ANOVA with Tukey's post-hoc test). This reduction in VMH was not different at 11 weeks. (C–J) Representative images of BDNF-immunoreactive neurons in Wistar rats (C,E,G,I) and GK rats (D,F,H,J) at 26 weeks of age. Broken lines in each image indicate the outline of PVN (C,D) and VMH (E,F) . No apparent difference was found in the PVN (C,D) and NTS (G,H) . By contrast, the number of BDNF-immunoreactive neurons in the VMH of GK rats (F) was fewer than that of Wistar rats (E) . At higher magnification, the difference between Wistar (I) and GK (J) rats was obvious. III; the third ventricle, IV; the fourth ventricle, cc; central canal. Scale bar = 500 μm (C–H) or 100 μm (I and J) .

Article Snippet: A chicken anti-human BDNF polyclonal antibody (1:100, G1641, Promega), a sheep anti-α-MSH antibody (1:30,000, AB5087, Chemicon, Temecula, CA), a biotinylated rabbit anti-chicken IgY (1:300, G2891, Promega), a biotinylated rabbit anti-sheep IgG (1:300, BA-6000, Vector Laboratories, Burlingame, CA) were used.

Techniques:

Effect of BDNF on NEFA levels before and after treatment to GK rats in fed and fasted conditions. Plasma NEFA levels in fed and 12 h-fasted conditions at time points before treatment (Day –1/0), immediately after termination of treatment (Day 6/7), and 4/5 days after termination of treatment (Day 10/11) were measured. Plasma NEFA level was higher in fasted condition at all time points measured in all groups [Pre(Day –1/0), p < 0.05 vs. fed conditions, Two-Way ANOVA with Tukey's post-hoc test]. At time point immediately after termination of treatment (Day 6/7), plasma NEFA levels in Wistar-BDNF and GK-BDNF groups were increased both at fed and fasting conditions. Especially, plasma NEFA levels in Wistar-BDNF and GK-BDNF groups at fasting condition were significantly higher than those in GK-Vehicle group at fasting condition ( * p < 0.05, Two-Way ANOVA with Tukey's post-hoc test). Such tendency continued to Day 10/11 but there was no significant difference at this time point.

Journal: Frontiers in Synaptic Neuroscience

Article Title: Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

doi: 10.3389/fnsyn.2013.00007

Figure Lengend Snippet: Effect of BDNF on NEFA levels before and after treatment to GK rats in fed and fasted conditions. Plasma NEFA levels in fed and 12 h-fasted conditions at time points before treatment (Day –1/0), immediately after termination of treatment (Day 6/7), and 4/5 days after termination of treatment (Day 10/11) were measured. Plasma NEFA level was higher in fasted condition at all time points measured in all groups [Pre(Day –1/0), p < 0.05 vs. fed conditions, Two-Way ANOVA with Tukey's post-hoc test]. At time point immediately after termination of treatment (Day 6/7), plasma NEFA levels in Wistar-BDNF and GK-BDNF groups were increased both at fed and fasting conditions. Especially, plasma NEFA levels in Wistar-BDNF and GK-BDNF groups at fasting condition were significantly higher than those in GK-Vehicle group at fasting condition ( * p < 0.05, Two-Way ANOVA with Tukey's post-hoc test). Such tendency continued to Day 10/11 but there was no significant difference at this time point.

Article Snippet: A chicken anti-human BDNF polyclonal antibody (1:100, G1641, Promega), a sheep anti-α-MSH antibody (1:30,000, AB5087, Chemicon, Temecula, CA), a biotinylated rabbit anti-chicken IgY (1:300, G2891, Promega), a biotinylated rabbit anti-sheep IgG (1:300, BA-6000, Vector Laboratories, Burlingame, CA) were used.

Techniques: Clinical Proteomics

Lack of alterations of melanocortines and effects of insulin and leptin on BDNF mRNA expression in GK rats. (A,B) Representative images of α-MSH-immunoreactive neurons in ARC of Wistar (A) and GK (B) rats. III; the third ventricle, Scale bar = 500 μm. (C) Numbers of α-MSH-immunoreactive neurons in Wistar and GK rats. (D) MC4R mRNA expressions in ARC and VMH were not different between Wistar and GK rats. (E) Repeated intraperitoneal injection of insulin (1 U/kg body weight, twice a day for 3 days) in GK rats did not alter BDNF mRNA level in VMH. (F) Single icv injection of insulin (10 mU) in Wistar rats did not alter BDNF mRNA levels in VMH. (G) Repeated icv injection of leptin (5 μ g, twice a day for 3 days) to the fasting Wistar rats had no significant effect on BDNF mRNA levels in VMH of Wistar rats.

Journal: Frontiers in Synaptic Neuroscience

Article Title: Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

doi: 10.3389/fnsyn.2013.00007

Figure Lengend Snippet: Lack of alterations of melanocortines and effects of insulin and leptin on BDNF mRNA expression in GK rats. (A,B) Representative images of α-MSH-immunoreactive neurons in ARC of Wistar (A) and GK (B) rats. III; the third ventricle, Scale bar = 500 μm. (C) Numbers of α-MSH-immunoreactive neurons in Wistar and GK rats. (D) MC4R mRNA expressions in ARC and VMH were not different between Wistar and GK rats. (E) Repeated intraperitoneal injection of insulin (1 U/kg body weight, twice a day for 3 days) in GK rats did not alter BDNF mRNA level in VMH. (F) Single icv injection of insulin (10 mU) in Wistar rats did not alter BDNF mRNA levels in VMH. (G) Repeated icv injection of leptin (5 μ g, twice a day for 3 days) to the fasting Wistar rats had no significant effect on BDNF mRNA levels in VMH of Wistar rats.

Article Snippet: A chicken anti-human BDNF polyclonal antibody (1:100, G1641, Promega), a sheep anti-α-MSH antibody (1:30,000, AB5087, Chemicon, Temecula, CA), a biotinylated rabbit anti-chicken IgY (1:300, G2891, Promega), a biotinylated rabbit anti-sheep IgG (1:300, BA-6000, Vector Laboratories, Burlingame, CA) were used.

Techniques: Expressing, Injection

Comparison of plasma leptin levels between GK-BDNF and GK-Vehicle pair-fed groups. In both groups, plasma leptin levels at Day 6 were decreased after BDNF and pair-fed treatments. At Day 10, plasma leptin level in GK-BDNF group remained low while that in GK-Vehicle pair-fed group was significantly elevated ( * p < 0.05, Student's t -test).

Journal: Frontiers in Synaptic Neuroscience

Article Title: Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

doi: 10.3389/fnsyn.2013.00007

Figure Lengend Snippet: Comparison of plasma leptin levels between GK-BDNF and GK-Vehicle pair-fed groups. In both groups, plasma leptin levels at Day 6 were decreased after BDNF and pair-fed treatments. At Day 10, plasma leptin level in GK-BDNF group remained low while that in GK-Vehicle pair-fed group was significantly elevated ( * p < 0.05, Student's t -test).

Article Snippet: A chicken anti-human BDNF polyclonal antibody (1:100, G1641, Promega), a sheep anti-α-MSH antibody (1:30,000, AB5087, Chemicon, Temecula, CA), a biotinylated rabbit anti-chicken IgY (1:300, G2891, Promega), a biotinylated rabbit anti-sheep IgG (1:300, BA-6000, Vector Laboratories, Burlingame, CA) were used.

Techniques: Comparison, Clinical Proteomics